Irish pharma company making ‘adulterated products’, US regulator claims – The Irish Times
US drug safety inspectors have warned one of Ireland’s largest pharmaceutical plants that it is failing to meet…
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Trump announces 100% tariff on pharma imports – The Irish Times
Most Irish pharmaceutical exports look set to escape 100 per cent tariffs announced overnight by the Trump administration.…
Diabetes Testing Moves Earlier—and Gets More Complex
By Alyx Arnett For decades, the clinical lab’s contribution to diabetes care followed a familiar script: A patient…
BioAge shows promise with new drug BGE-102 in early trial
The company expands its Phase 1 trial after early signals show BGE-102’s potential to address inflammation beyond the…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…